somatotroph is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
=== Cl–Cor === G. Marius Clore FRS (born 1955), American chemist, known for foundational work in three-dimensional protein and nucleic acid structure determination by nuclear magnetic resonance spectroscopy Edward L.
For some professional career programs, students are required to take the Saber-Pro test, in their final year of undergraduate academic education. Public spending on education as a proportion of gross domestic product in 2015 was 4.49%. This represented 15.05% of total government expenditure. The primary and secondary gross enrolment ratios stood at 113.56% and 98.09% respectively. School-life expectancy was 14.42 years. A total of 94.58% of the population aged 15 and older were recorded as literate, including 98.66% of those aged 15–24.
==== Māyā Cave (Third complex, cave 224, c.550–600 CE) ==== Maya Cave (Cave 224) of "III Anlage" is one of the most famous caves of the Third Period. It is dated to circa 550–600 CE, and possibly follows the events of the Turk uprising against the Rouran Khaganate in 552 CE and the subsequent Turk expansion. The helmets of the Knights depicted in some of the murals have been said to be characteristic pear-shaped segmented helmets of the Turkic type. A famous mural of the Mourning of the Buddha at his Cremation appears in Maya Cave (224), from the rear passage of the cave, with various figures in ethnic costumes. Three of the men among the mourners cut their forehead skin or chest with their knives, a practice of self-mutilation practiced by the Scythians. One of the mourners if is thought to be a Turk.
Organizations also often attempt to ostracize and isolate whistleblowers by undermining their concerns by suggesting that they are groundless, carrying out inadequate investigations, or ignoring them altogether. Whistleblowers may also be disciplined, suspended, and reported to professional bodies upon manufactured pretexts. Such extreme experiences of threat and loss inevitably cause severe distress and sometimes mental illness, sometimes lasting for years afterwards. This mistreatment also deters others from coming forward with concerns. Thus, poor practices remain hidden behind a wall of silence, and prevent any organization from experiencing the improvements that may be afforded by intelligent failure. Some whistleblowers who break ranks with their organizations have had their mental stability questioned, such as Adrian Schoolcraft, the NYPD veteran who alleged falsified crime statistics in his department and was forcibly committed to a mental institution. Conversely, the emotional strain of a whistleblower investigation is devastating to the accused's family.
Nickel-78 is one of the element's heaviest known isotopes. With 28 protons and 50 neutrons, nickel-78 is doubly magic, resulting in much greater nuclear binding energy and stability despite a lopsided neutron-proton ratio. Its half-life is 122 ± 5.1 milliseconds. Due to its magic neutron number, 78Ni is believed to have an important role in supernova nucleosynthesis of elements heavier than iron. 78Ni, along with N = 50 isotones 79Cu and 80Zn, are thought to constitute a waiting point in the r-process, where further neutron capture is delayed by the shell gap and a buildup of isotopes around A = 80 results.
Sources: en.wikipedia.org
=== Pharmacokinetics === The oral bioavailability of cannabidiol is approximately 6% in fasting state and 36.5–57.3% in fed-state in humans, while its bioavailability via inhalation is 11–45% (mean 31%). The oral bioavailability of cannabidiol varies based on several factors such as formulation, dose, and food intake. The sublingual bioavailability of cannabidiol is approximately 12–35%. The elimination half-life of cannabidiol in blood is 56–61 hours after oral doses twice per day over 7 days. Based on the pharmacokinetic analysis of long-term dosing of cannabidiol in humans, the terminal elimination half-life is estimated to be >134 hours. Cannabidiol is metabolized in the liver as well as in the intestines by cytochrome P450 enzymes.
Vasquez ran for reelection in 2024 against Republican former Congresswoman Yvette Herrell in a rematch of the 2022 race. Vasquez once again defeated Herrell, this time by 11,032 votes, despite Donald Trump narrowly flipping New Mexico's 2nd district in the concurrent presidential election.
=== Badger's rule === For many kinds of samples, the assignments are known, i.e. which bond deformation(s) are associated with which frequency. In such cases further information can be gleaned about the strength on a bond, relying on the empirical guideline called Badger's rule. Originally published by Richard McLean Badger in 1934, this rule states that the strength of a bond (in terms of force constant) correlates with the bond length. That is, increase in bond strength leads to corresponding bond shortening and vice versa.
=== Blo–Bou === Katharine Burr Blodgett (1898–1979), American surface chemist and physicist and inventor of nonreflective glass Suzanne Blum (born 1978), American chemist developing single-molecule and single-particle fluorescence microscopy Katharine Blunt (1876–1954), American chemist and nutritionist focusing on home economics, food chemistry and nutrition Herman Boerhaave (1668–1738) Dutch chemist, botanist, Christian humanist & physician, first to isolate urea from urine Kristie Boering (born 1963), American chemist and planetary scientist studying atmospheric chemistry and mass transport in the extraterrestrial atmosphere Alexei Bogdanov (born 1935), Soviet and Russian biochemist and molecular biologist known for fundamental contributions to ribosome structure and function, nucleic acid-protein interactions, and protein biosynthesis mechanisms. Olga Bogdanova (1896–1982), Soviet chemist who specialized in organic catalysis Dale L. Boger (born 1953), American chemist working on natural product synthesis, synthetic methodology, medicinal chemistry, and combinatorial chemistry Paul Emile Lecoq de Boisbaudran (1838–1912), French chemist who discovered gallium, samarium and dysprosium Jan Boldingh (1915–2003), Dutch chemist known for new analytic techniques such as gas-chromatography and others Alexander Borodin (1833–1887), Russian chemist and composer.
Sources: en.wikipedia.org
== Medical uses == Buserelin is approved for the treatment of hormone-responsive cancers including prostate cancer and premenopausal breast cancer, sex hormone-dependent uterine diseases including endometrial hyperplasia, endometriosis, and uterine fibroids, and in assisted reproduction for female infertility. It is also used off-label for the treatment of precocious puberty, as a puberty blocker in transgender children, and as a component of transgender hormone therapy. In ovulation induction, buserelin is used for pituitary suppression as an adjunct to gonadotropin administration. It has also been assessed as a nasal spray for use as a hormonal contraceptive in women, with a 96% anovulation rate.
It is estimated that 6.1 million tonnes of uranium exists in ores that are economically viable at US$130 per kg of uranium, while 35 million tonnes are classed as mineral resources (reasonable prospects for eventual economic extraction). Australia has 28% of the world's known uranium ore reserves and the world's largest single uranium deposit is located at the Olympic Dam Mine in South Australia. There is a significant reserve of uranium in Bakouma, a sub-prefecture in the prefecture of Mbomou in the Central African Republic. Some uranium also originates from dismantled nuclear weapons. For example, in 1993–2013 Russia supplied the United States with 15,000 tonnes of low-enriched uranium within the Megatons to Megawatts Program. An additional 4.6 billion tonnes of uranium are estimated to be dissolved in sea water (Japanese scientists in the 1980s showed that extraction of uranium from sea water using ion exchangers was technically feasible). There have been experiments to extract uranium from sea water, but the yield has been low due to the carbonate present in the water. In 2012, ORNL researchers announced the successful development of a new absorbent material dubbed HiCap which performs surface retention of solid or gas molecules, atoms or ions and also effectively removes toxic metals from water, according to results verified by researchers at Pacific Northwest National Laboratory.
Is it morally right to tamper with nature? Is one playing God when creating new life? What happens if a synthetic organism accidentally escapes? What if an individual misuses synthetic biology and creates a harmful entity (e.g., a biological weapon)? Who will have control of and access to the products of synthetic biology? Who will gain from these innovations? Investors? Medical patients? Industrial farmers? Does the patent system allow patents on living organisms? What about parts of organisms, like HIV resistance genes in humans? What if a new creation is deserving of moral or legal status? The ethical aspects of synthetic biology has three main features: biosafety, biosecurity, and the creation of new life forms. Other ethical issues mentioned include the regulation of new creations, patent management of new creations, benefit distribution, and research integrity. Ethical issues have surfaced for recombinant DNA and genetically modified organism (GMO) technologies and extensive regulations of genetic engineering and pathogen research were in place in many jurisdictions. Amy Gutmann, former head of the Presidential Bioethics Commission, argued that we should avoid the temptation to over-regulate synthetic biology in general, and genetic engineering in particular. According to Gutmann, "Regulatory parsimony is especially important in emerging technologies...where the temptation to stifle innovation on the basis of uncertainty and fear of the unknown is particularly great.
1961), author of Penguin Books Users: How Big Tech Took Control and How to Fight Back; filmmaker, politician and social activist; advocate for children's rights in the digital world; establishing standards for online safety and privacy across the world; sits as a crossbench peer in the United Kingdom's House of Lords; she is an advisor to the Institute for Ethics of artificial intelligence at Oxford University, a commissioner on the Broadband Commission for Sustainable Development, and founder of 5Rights Foundation; sister of record producer Adam Kidron; daughter of British Israeli of South African origin, Michael Kidron, founder of leftist Pluto Press; niece of Socialist Workers Party founder Tony Cliff and activist Chanie Rosenberg, and the cousin of historian Donny Gluckstein.; appointed Officer of the Order of the British Empire (OBE) in the 2012 Birthday Honours for services to drama. Sophia King (later Fortnum; b. 1781/2, d. in or after 1805) Gothic novelist and poet, and sister of Gothic writer Charlotte Dacre. She contributed to poetry periodicals under the nom-de-plume "Sappho".
== External links == The Scar Free Foundation website The Scar Free Foundation 2022 Impact Report Centre for Appearance Research, UWE The Scar Free Foundation and Health and Care Research Wales Programme of Regenerative Medicine
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.